Maxim Group LLC Announces Strategic Promotion in Biotechnology Research

NEW YORK, April 02, 2018 (GLOBE NEWSWIRE) -- Maxim Group LLC, a leading full service investment banking, securities and wealth management firm today announced the enhancement of its Healthcare Equity Research practice with the promotion of Dr. Jason McCarthy, Ph.D. to Senior Managing Director of Biotechnology.

“Maxim Group continues to build one of the premier proprietary research platforms on Wall Street, with an emphasis on emerging growth and paradigm-shifting businesses. Biotechnology is an important vertical in our healthcare practice and we are proud to have Jason leading this effort,” said Anthony V. Vendetti, Executive Managing Director of Research for Maxim Group. The biotechnology team currently covers over 50 research names and expects to double research coverage over the next year as more resources are added to build out this important vertical.

In his expanded role, Dr. McCarthy will work with Anthony Vendetti in the development and implementation of Maxim Group’s biotechnology research strategy with a key focus on product expansion on the Institutional and Wealth Management platforms. Dr. McCarthy received his doctoral degree in Biomedical Research (Albert Einstein College of Medicine) and Molecular Biology (Adelphi University), as well as a B.S. in Biochemistry from Stony Brook University.

Michael Rabinowitz, Chairman & CEO of Maxim Group, added “Our commitment to build a first class healthcare practice has never wavered, and Dr. McCarthy’s well-deserved promotion is another significant step in that process. As we continue our firm-wide expansion, we expect to add other high quality professionals to the Maxim Group Research team.”

About Maxim Group LLC

Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales & trading, equity research and prime brokerage services to a diverse range of corporate clients, institutional investors and high net worth individuals. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and the Municipal Securities Rulemaking Board (MSRB), and is a member of the following: Financial Industry Regulatory Authority (FINRA); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and NYSE Arca, Inc. To learn more about Maxim Group, visit                                   

For further information please contact:

John J. Garrity
Chief Marketing Officer